Full article view2017-09-21T12:08:00+00:00
Back to News & Insights »

Is Indication-Specific Drug Pricing the Solution?

 

As rapidly as cancer treatments are advancing, so is pricing. To help find ways to reduce drug costs, payers must focus on exploring types of value-based payments. Learn more as we garner insights from a 2015 Precision for Value survey and further examining indication-based payment.

To read the full article, please click here.

 

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.

OK